Related references
Note: Only part of the references are listed.Nutlin kills cancer cells via mitochondrial p53
Eugenia Morselli et al.
CELL CYCLE (2011)
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
K. Kojima et al.
LEUKEMIA (2010)
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
Paola Secchiero et al.
BLOOD (2009)
MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
Martin Enge et al.
CANCER CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells
Angelina V. Vaseva et al.
CELL CYCLE (2009)
Nutlin-3 Affects Expression and Function of Retinoblastoma Protein ROLE OF RETINOBLASTOMA PROTEIN IN CELLULAR RESPONSE TO NUTLIN-3
Wei Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
H. Seifert et al.
LEUKEMIA (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Targeting the MDM2-p53 interaction for cancer therapy
Sanjeev Shangary et al.
CLINICAL CANCER RESEARCH (2008)
Skp2 suppresses p53-dependent apoptosis by inhibiting p300
Mayumi Kitagawa et al.
MOLECULAR CELL (2008)
Mdm2 Regulates p53 mRNA Translation through Inhibitory Interactions with Ribosomal Protein L26
Yaara Ofir-Rosenfeld et al.
MOLECULAR CELL (2008)
The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML
K. Kojima et al.
LEUKEMIA (2008)
A complex barcode underlies the heterogeneous response of p53 to stress
Fiona Murray-Zmijewski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines
M. Kitagawa et al.
ONCOGENE (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations
Alyson W. MacInnes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
Chris Saddler et al.
BLOOD (2008)
Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis
Charles W. Ross et al.
CLINICAL CANCER RESEARCH (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin
Baoli Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration
Simone Di Giovanni et al.
EMBO JOURNAL (2006)
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
Kensuke Kojima et al.
BLOOD (2006)
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ke Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Chad D. Knights et al.
JOURNAL OF CELL BIOLOGY (2006)
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
Paola Secchiero et al.
BLOOD (2006)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
S Francoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
T Stühmer et al.
BLOOD (2005)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin
M Takagi et al.
CELL (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data
M Lin et al.
BIOINFORMATICS (2004)
The ubiquitin ligase COP1 is a critical negative regulator of p53
D Dornan et al.
NATURE (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Integral role of Noxa in p53-mediated apoptotic response
T Shibue et al.
GENES & DEVELOPMENT (2003)
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng et al.
CELL (2003)
NQ01 stabilizes p53 through a distinct pathway
G Asher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
DL Stirewalt et al.
BLOOD (2001)
Share Paper
